Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

fda-approval

A collection of 9 Posts

FDA Approves Regeneron's Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma post image

FDA Approves Regeneron's Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment post image

FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment

FDA Approves Johnson & Johnson's Simponi for Pediatric Ulcerative Colitis post image

FDA Approves Johnson & Johnson's Simponi for Pediatric Ulcerative Colitis

Envoy Medical Receives FDA Approval for Final Stage of Fully Implanted Acclaim Cochlear Implant Trial post image

Envoy Medical Receives FDA Approval for Final Stage of Fully Implanted Acclaim Cochlear Implant Trial

FDA Fast-Tracks Controversial Autism-Related Drug Approval with GSK, Drawing Expert Scrutiny post image

FDA Fast-Tracks Controversial Autism-Related Drug Approval with GSK, Drawing Expert Scrutiny

uniQure's AMT-130 Gene Therapy Shows Breakthrough Efficacy in Huntington's Trial, Accelerating FDA Pathway post image

uniQure's AMT-130 Gene Therapy Shows Breakthrough Efficacy in Huntington's Trial, Accelerating FDA Pathway

Generic Mifepristone Receives FDA Approval Amidst Heightened Political Scrutiny post image

Generic Mifepristone Receives FDA Approval Amidst Heightened Political Scrutiny

Rubicon Research IPO: Strong Fundamentals and US Market Expansion Drive Growth post image

Rubicon Research IPO: Strong Fundamentals and US Market Expansion Drive Growth

Eli Lilly's Orforglipron Shows Promising Clinical Trial Results for Weight Loss and Type 2 Diabetes post image

Eli Lilly's Orforglipron Shows Promising Clinical Trial Results for Weight Loss and Type 2 Diabetes